RGEN Share Price

Open 35.33 Change Price %
High 35.73 1 Day 0.05 0.14
Low 35.04 1 Week -0.56 -1.57
Close 35.11 1 Month 0.47 1.36
Volume 146940 1 Year 7.93 29.18
52 Week High 36.10
52 Week Low 21.11
RGEN Important Levels
Resistance 2 35.75
Resistance 1 35.49
Pivot 35.29
Support 1 34.73
Support 2 34.47
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
SIRI 5.13 1.18%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
CYTR 0.83 36.07%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
CPSL 0.09 50.00%
LOCM 0.09 50.00%
RITT 0.03 50.00%
OPTT 2.74 49.73%
CYTR 0.83 36.07%
WRES 0.09 28.57%
BSDM 0.62 26.53%
ATRM 1.89 26.00%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Repligen Corporation (NASDAQ: RGEN)

RGEN Technical Analysis 5
As on 24th Apr 2017 RGEN Share Price closed @ 35.11 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 30.29 & Strong Buy for SHORT-TERM with Stoploss of 32.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
RGEN Target for April
1st Target up-side 37.88
2nd Target up-side 39.75
3rd Target up-side 41.63
1st Target down-side 32.52
2nd Target down-side 30.65
3rd Target down-side 28.77
RGEN Other Details
Segment EQ
Market Capital 156846352.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.repligen.com
RGEN Address
RGEN
Building 1
Suite 100
Waltham, MA 02453
United States
Phone: 781-250-0111
Fax: 781-250-0115
RGEN Latest News
Interactive Technical Analysis Chart Repligen Corporation ( RGEN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Repligen Corporation
RGEN Business Profile
Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. The Company manufactures Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. It also supplies several growth factor products used to increase cell culture productivity in biomanufacturing. The Company develops and markets a series of OPUS (Open Platform User Specified) single-use chromatography columns used in the biologics purification process.